Literature DB >> 3917480

Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.

M E Andrew, A M Churilla, T R Malek, V L Braciale, T J Braciale.   

Abstract

Interleukin 2 (IL 2) is a lymphocyte-specific growth hormone, whose effect on lymphocyte proliferation is exerted through a cell surface receptor expressed on activated lymphocytes. In this report we have used monoclonal antibodies directed to the murine IL 2 receptor to examine the regulation of the IL 2 receptor expression on cloned populations of influenza virus-specific CTL. The CTL clones, which are dependent on both specific antigenic stimulation and exogenous IL 2 for continuous in vitro propagation, express high levels of the IL 2 receptor shortly after antigenic stimulation (day 2 or 3). Over the next 5 to 8 days of in vitro cultivation in IL 2-containing medium, these cloned CTL cells express decreasing levels of IL 2 receptor. Concomitant with this fall in IL 2 receptor expression, the cells become refractory to the IL 2 proliferative stimulus. The cloned cells remain refractory to IL 2 until specifically stimulated by antigen, which induces high levels of the IL 2 receptor on the cells and renders the cells sensitive to IL 2 once again. These results support the concept that IL 2 receptor expression on activated T lymphocytes is transitory and that receptor expression is endogenously regulated in the activated T lymphocytes. These results also suggest that antigen plays a primary role in regulating T lymphocyte proliferation by maintaining IL 2 receptor levels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917480

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression.

Authors:  M E Andrew; D B Boyle; P L Whitfeld; L J Lockett; I D Anthony; A R Bellamy; G W Both
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

3.  Soluble Il-2 receptor serum levels--a marker for disease progression in patients with HIV-1 infection.

Authors:  C Schulte; M Meurer
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Effects of recombinant interleukin 2 on immunological effector cells of the peripheral blood in patients with HBe antigen-positive chronic hepatitis.

Authors:  Y Mizoguchi; T Shin; Y Sakagami; S Seki; T Kuroki; K Kobayashi; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1988-04

5.  Establishment of cytotoxic T-cell clones specific for cells infected with mouse hepatitis virus.

Authors:  K Yamaguchi; S Kyuwa; K Nakanaga; M Hayami
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.

Authors:  T J Braciale; V L Braciale; M Winkler; I Stroynowski; L Hood; J Sambrook; M J Gething
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

7.  Regulation of the growth and functions of cloned murine large granular lymphocyte lines by resident macrophages.

Authors:  N Minato; T Amagai; J Yodoi; T Diamanstein; S Kano
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

8.  Regulation of T lymphocyte proliferation. Interleukin 2-mediated induction of c-myb gene expression is dependent on T lymphocyte activation state.

Authors:  A M Churilla; T J Braciale; V L Braciale
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

9.  Impaired interleukin-2 receptor expression on lymphocytes from patients with chronic active hepatitis type B.

Authors:  D S Ahn; H C Jang; J K Ahn; C Y Yim; D G Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.